How splicing confers treatment resistance in prostate cancer

Abstract

A splice variant of the androgen receptor that drives prostate cancer resistance translocates into the nucleus using a different mechanism from the full-length receptor and exhibits distinct molecular properties once inside.

Keywords

• AR-V7
• prostate cancer
• nuclear import
• intranuclear mobility
• transcriptional activity
• androgen receptor